Interferon-gamma (IFN-γ)-mediated retinal ganglion cell death in human tyrosinase t cell receptor transgenic mouse

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Husain, Shahid ^a   Abdul, Yasir ^a   Webster, Christine ^b   Chatterjee, Shilpak ^b   Kesarwani, Pravin ^b   Mehrotra, Shikhar ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 9; CD3 ANTIGEN; FLUOROGOLD; GAMMA INTERFERON; GLIAL FIBRILLARY ACIDIC PROTEIN; T LYMPHOCYTE RECEPTOR; TYROSINASE T CELL RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL DEATH; CELL FUNCTION; CELL LABELING; CONTROLLED STUDY; DISEASE MARKER; ELECTRORETINOGRAM; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE FUNCTION; MOUSE; NERVE FIBER; NEUROPATHOLOGY; NONHUMAN; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RETINA DISEASE; RETINA GANGLION CELL; TRANSGENIC MOUSE; UPREGULATION; VISUAL STIMULATION; VITILIGO; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERON-GAMMA; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MONOPHENOL MONOOXYGENASE; RECEPTORS, ANTIGEN, T-CELL; RETINA; RETINAL GANGLION CELLS;

EID: 84896541209     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089392     Document Type: Article

References (59)

1. Qu J, Wang D, Grosskreutz CL (2010) Mechanisms of retinal ganglion cell injury and defense in glaucoma. Exp Eye Res 91: 48-53.
2. Osborne NN, Casson RJ, Wood JP, Chidlow G, Graham M, et al. (2004) Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog Retin Eye Res 23: 91-147. (Pubitemid 38180539)
3. Allingham RR, Liu Y, Rhee DJ (2009) The genetics of primary open-angle glaucoma: a review. Exp Eye Res 88: 837-844.
4. Wax MB (2011) The case for autoimmunity in glaucoma. Exp Eye Res 93: 187-190.
5. Quigley HA (1999) Neuronal death in glaucoma. Prog Retin Eye Res 18: 39-57. (Pubitemid 28457038)
6. Almasieh M, Wilson AM, Morquette B, Cueva Vargas JL, Di Polo A (2012) The molecular basis of retinal ganglion cell death in glaucoma. Prog Retin Eye Res 31: 152-181.
7. McKinnon SJ, Lehman DM, Kerrigan-Baumrind LA, Merges CA, Pease ME, et al. (2002) Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension. Invest Ophthalmol Vis Sci 43: 1077-1087. (Pubitemid 34258276)
8. Abcouwer SF, Shanmugam S, Gomez PF, Shushanov S, Barber AJ, et al. (2008) Effect of IL-1beta on survival and energy metabolism of R28 and RGC-5 retinal neurons. Invest Ophthalmol Vis Sci 49: 5581-5592.
9. Nguyen SM, Alexejun CN, Levin LA (2003) Amplification of a reactive oxygen species signal in axotomized retinal ganglion cells. Antioxid Redox Signal 5: 629-634. (Pubitemid 37315151)
10. Tezel G (2006) Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences. Prog Retin Eye Res 25: 490-513. (Pubitemid 44389961)
11. Caspi RR (2010) A look at autoimmunity and inflammation in the eye. J Clin Invest 120: 3073-3083.
12. Niederkorn JY (2006) See no evil, hear no evil, do no evil: the lessons of immune privilege. Nat Immunol 7: 354-359.
13. Cousins SW, McCabe MM, Danielpour D, Streilein JW (1991) Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor. Invest Ophthalmol Vis Sci 32. 2201-2211
14. Albert ML, Austin LM, Darnell RB (2000) Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration. Ann Neurol 47: 9-17. (Pubitemid 30033645)
15. Fearon DT, Locksley RM (1996) The instructive role of innate immunity in the acquired immune response. Science 272: 50-53.
16. Li Y, Uccelli A, Laxer KD, Jeong MC, Vinters HV, et al. (1997) Local-clonal expansion of infiltrating T lymphocytes in chronic encephalitis of Rasmussen. J Immunol 158: 1428-1437. (Pubitemid 127469970)
17. Nishimura MI, Avichezer D, Custer MC, Lee CS, Chen C, et al. (1999) MHC class I-restricted recognition of a melanoma antigen by a human CD4+ tumor infiltrating lymphocyte. Cancer Res 59: 6230-6238. (Pubitemid 30035647)
18. Mehrotra S, Al-Khami AA, Klarquist J, Husain S, Naga O, et al. (2012) A coreceptor-independent transgenic human TCR mediates anti-tumor and antiself immunity in mice. J Immunol 189: 1627-1638.
19. Husain S, Abdul Y, Crosson CE (2012) Preservation of retina ganglion cell function by morphine in a chronic ocular-hypertensive rat model. Invest Ophthalmol Vis Sci 53: 4289-4298.
20. Abdul Y, Akhter N, Husain S (2013) Delta-Opioid Agonist SNC-121 Protects Retinal Ganglion Cell Function in a Chronic Ocular Hypertensive Rat Model. Invest Ophthalmol Vis Sci 54: 1816-1828.
21. Husain S, Potter DE, Crosson CE (2009) Opioid receptor-activation: retina protected from ischemic injury. Invest Ophthalmol Vis Sci 50: 3853-3859.
22. Husain S, Liou GI, Crosson CE (2011) Opioid receptor activation: suppression of ischemia/reperfusion-induced production of TNF-alpha in the retina. Invest Ophthalmol Vis Sci 52: 2577-2583.
23. Holder GE (2001) Pattern electroretinography (PERG) and an integrated approach to visual pathway diagnosis. Prog Retin Eye Res 20: 531-561. (Pubitemid 32523897)
24. Gregg RK, Nichols L, Chen Y, Lu B, Engelhard VH (2010) Mechanisms of spatial and temporal development of autoimmune vitiligo in tyrosinase-specific TCR transgenic mice. J Immunol 184: 1909-1917.
25. Mashiah J, Brenner S (2008) Possible mechanisms in the induction of vitiligo-like hypopigmentation by topical imiquimod. Clin Exp Dermatol 33: 74-76. (Pubitemid 350308512)
26. van den Boorn JG, Konijnenberg D, Dellemijn TA, van der Veen JP, Bos JD, et al. (2009) Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients. J Invest Dermatol 129: 2220-2232.
27. Wang CQ, Cruz-Inigo AE, Fuentes-Duculan J, Moussai D, Gulati N, et al. (2011) Th17 cells and activated dendritic cells are increased in vitiligo lesions. PLoS One 6: e18907.
28. Hernandez MR (2000) The optic nerve head in glaucoma: role of astrocytes in tissue remodeling. Prog Retin Eye Res 19: 297-321. (Pubitemid 30122725)
29. Hernandez MR, Pena JD (1997) The optic nerve head in glaucomatous optic neuropathy. Arch Ophthalmol 115: 389-395. (Pubitemid 27131307)
30. Morrison JC, Dorman-Pease ME, Dunkelberger GR, Quigley HA (1990) Optic nerve head extracellular matrix in primary optic atrophy and experimental glaucoma. Arch Ophthalmol 108: 1020-1024. (Pubitemid 20216027)
31. Son JL, Soto I, Oglesby E, Lopez-Roca T, Pease ME, et al. (2010) Glaucomatous optic nerve injury involves early astrocyte reactivity and late oligodendrocyte loss. Glia 58: 780-789.
32. Jung KI, Kim JH, Park HY, Park CK (2013) Neuroprotective effects of cilostazol on retinal ganglion cell damage in diabetic rats. J Pharmacol Exp Ther 345: 457-463.
33. Aizu Y, Oyanagi K, Hu J, Nakagawa H (2002) Degeneration of retinal neuronal processes and pigment epithelium in the early stage of the streptozotocindiabetic rats. Neuropathology 22: 161-170. (Pubitemid 35252706)
34. Tura A, Schuettauf F, Monnier PP, Bartz-Schmidt KU, Henke-Fahle S (2009) Efficacy of Rho-kinase inhibition in promoting cell survival and reducing reactive gliosis in the rodent retina. Invest Ophthalmol Vis Sci 50: 452-461.
35. Amadi-Obi A, Yu CR, Liu X, Mahdi RM, Clarke GL, et al. (2007) TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat Med 13: 711-718. (Pubitemid 46889754)
36. Tezel G, Wax MB (2000) Increased production of tumor necrosis factor-alpha by glial cells exposed to simulated ischemia or elevated hydrostatic pressure induces apoptosis in cocultured retinal ganglion cells. J Neurosci 20: 8693-8700.
37. Gargiulo A, Bonetti C, Montefusco S, Neglia S, Di Vicino U, et al. (2009) AAVmediated tyrosinase gene transfer restores melanogenesis and retinal function in a model of oculo-cutaneous albinism type I (OCA1). Mol Ther 17: 1347-1354.
38. Huang P, Zhang SS, Zhang C (2009) The two sides of cytokine signaling and glaucomatous optic neuropathy. J Ocul Biol Dis Infor 2: 78-83.
39. Egwuagu CE, Mahdi RM, Chan CC, Sztein J, Li W, et al. (1999) Expression of interferon-gamma in the lens exacerbates anterior uveitis and induces retinal degenerative changes in transgenic Lewis rats. Clin Immunol 91: 196-205. (Pubitemid 29203419)
40. Chatterjee S, Eby J, Al-Khami AA, Soloshchenko M, Kang HK, et al. (2013) A Quantitative Increase in Regulatory T Cells Controls Development of Vitiligo. J Invest Dermatol. (In Press.
41. Yang X, Luo C, Cai J, Powell DW, Yu D, et al. (2011) Neurodegenerative and Inflammatory Pathway Components Linked to TNF-alpha/TNFR1 Signaling in the Glaucomatous Human Retina. Invest Ophthalmol Vis Sci 52: 8442-8454.
42. Yuan L, Neufeld AH (2000) Tumor necrosis factor-alpha: a potentially neurodestructive cytokine produced by glia in the human glaucomatous optic nerve head. Glia 32: 42-50.
43. Wax MB, Tezel G (2009) Immunoregulation of retinal ganglion cell fate in glaucoma. Exp Eye Res 88: 825-830.
44. Tezel G, Wax MB (2004) The immune system and glaucoma. Curr Opin Ophthalmol 15: 80-84. (Pubitemid 38457123)
45. Grus FH, Joachim SC, Wuenschig D, Rieck J, Pfeiffer N (2008) Autoimmunity and glaucoma. J Glaucoma 17: 79-84. (Pubitemid 351321483)
46. Quigley HA, Nickells RW, Kerrigan LA, Pease ME, Thibault DJ, et al. (1995) Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci 36: 774-786.
47. Garcia-Valenzuela E, Shareef S, Walsh J, Sharma SC (1995) Programmed cell death of retinal ganglion cells during experimental glaucoma. Exp Eye Res 61: 33-44.
48. Kerrigan LA, Zack DJ, Quigley HA, Smith SD, Pease ME (1997) TUNELpositive ganglion cells in human primary open-angle glaucoma. Arch Ophthalmol 115: 1031-1035. (Pubitemid 27328493)
49. Yang J, Patil RV, Yu H, Gordon M, Wax MB (2001) T cell subsets and sIL-2R/ IL-2 levels in patients with glaucoma. Am J Ophthalmol 131: 421-426. (Pubitemid 32273426)
50. Joachim SC, Bruns K, Lackner KJ, Pfeiffer N, Grus FH (2007) Antibodies to alpha B-crystallin, vimentin, and heat shock protein 70 in aqueous humor of patients with normal tension glaucoma and IgG antibody patterns against retinal antigen in aqueous humor. Curr Eye Res 32: 501-509. (Pubitemid 47035879)
51. Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, et al. (1998) Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest 102: 783-791.
52. Antonetti DA, Barber AJ, Bronson SK, Freeman WM, Gardner TW, et al. (2006) Diabetic retinopathy: seeing beyond glucose-induced microvascular disease. Diabetes 55: 2401-2411. (Pubitemid 44871140)
53. Sima AA, Zhang WX, Cherian PV, Chakrabarti S (1992) Impaired visual evoked potential and primary axonopathy of the optic nerve in the diabetic BB/ W-rat. Diabetologia 35: 602-607.
54. Bajaire BJ, Paipilla DF, Arrieta CE, Oudovitchenko E (2011) Mixed vascular occlusion in a patient with interferon-associated retinopathy. Case Rep Ophthalmol 2: 23-29.
55. Ayaki M (1994) Development of neovascular glaucoma in the course of interferon alfa therapy for hepatitis type C. Br J Ophthalmol 78: 238. (Pubitemid 24070640)
56. Kwon YS, Choe YH, Chin HS (2001) Development of glaucoma in the course of interferon alpha therapy for chronic hepatitis B. Yonsei Med J 42: 134-136.
57. Rachitskaya AV, Lee RK, Dubovy SR, Schiff ER (2012) Combined central retinal vein and central retinal artery occlusions and neovascular glaucoma associated with interferon treatment. Eur J Ophthalmol 22: 284-287.
58. Chua J, Vania M, Cheung CM, Ang M, Chee SP, et al. (2012) Expression profile of inflammatory cytokines in aqueous from glaucomatous eyes. Mol Vis 18: 431-438.
59. Malvitte L, Montange T, Vejux A, Baudouin C, Bron AM, et al. (2007) Measurement of inflammatory cytokines by multicytokine assay in tears of patients with glaucoma topically treated with chronic drugs. Br J Ophthalmol 91: 29-32. (Pubitemid 46094003)